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Abstract
The bone and immune systems are closely interconnected. The immediate inflammatory response after fracture is known to
trigger a healing cascade which plays an important role in bone repair. Toll-like receptor 4 (TLR4) is a member of a highly
conserved receptor family and is a critical activator of the innate immune response after tissue injury. TLR4 signaling has
been shown to regulate the systemic inflammatory response induced by exposed bone components during long-bone
fracture. Here we tested the hypothesis that TLR4 activation affects the healing of calvarial defects. A 1.8 mm diameter
calvarial defect was created in wild-type (WT) and TLR4 knockout (TLR42/2) mice. Bone healing was tested using
radiographic, histologic and gene expression analyses. Radiographic and histomorphometric analyses revealed that calvarial
healing was accelerated in TLR42/2mice. More bone was observed in TLR42/2mice compared to WT mice at postoperative
days 7 and 14, although comparable healing was achieved in both groups by day 21. Bone remodeling was detected in
both groups on postoperative day 28. In TLR42/2mice compared to WT mice, gene expression analysis revealed that higher
expression levels of IL-1b, IL-6, TNF-a,TGF-b1, TGF-b3, PDGF and RANKL and lower expression level of RANK were detected
at earlier time points (# postoperative 4 days); while higher expression levels of IL-1b and lower expression levels of VEGF,
RANK, RANKL and OPG were detected at late time points (. postoperative 4 days). This study provides evidence of
accelerated bone healing in TLR42/2 mice with earlier and higher expression of inflammatory cytokines and with increased
osteoclastic activity. Further work is required to determine if this is due to inflammation driven by TLR4 activation.
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Introduction
The skeletal and immune systems are interconnected and share
multiple signaling pathways [1]. The inflammatory stage of
healing that occurs immediately after fracture is non-specific and
shares signaling pathways with non-skeletal injuries like skin
wound healing. Bone components exposed by long bone fracture
possessed immunologic properties that play an important role in
the induction of local, but not systemic, inflammation [2–3].
Inflammation promotes cell proliferation and migration into the
fracture site, triggering a healing cascade within damaged bone
[4]. Inflammation has a well-established role in promoting long
bone regeneration. The use of nonsteroidal anti-inflammatory
drugs is contra-indicated in patients with bone injuries [5].
Fracture repair is significantly delayed in COX-22/2 mice,
suggesting that efforts to blunt inflammation may be deleterious
to fracture healing [6]. However, other studies have observed
accelerated fracture repair in the absence of an adaptive immune
system [7]. The role of the inflammatory response in bone
regeneration is more complex than originally envisioned and is not
fully understood.
Toll-like receptors (TLRs) play an essential role in innate
recognition of microbial products and are critical activators of the
innate immune response. More than ten TLRs have been shown
to recognize distinct microbial products, such as microbial
membrane lipids or nucleic acids. Another unique role of TLRs
is to sense cellular stress or tissue damage by responding to
endogenous ligands released from necrotic cells and damaged
tissues [8]. Direct TLR signaling inhibits RANKL-mediated
osteoclast differentiation, while TLR activation has also been
shown to enhance osteoclast differentiation by inducing RANKL
and TNF-a expression in osteoblasts [9]. Thus, the role of TLRs in
bone healing remains unclear and deserves further investigation
[10–12].
Toll-like receptor 4 (TLR4), a cell surface TLR, plays a unique
role in sensing tissue damage. TLR4 signaling is activated in
response to tissue injury, resulting in the induction of a sterile
inflammatory cascade [13]. TLR4 has also been implicated in
regulating the systemic inflammatory response following bilateral
femoral fracture [14]. Whether TLR4 plays a role in the local
inflammatory response to calvarial defects and the impacts of this
response on healing remains unknown.
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In the current study, we hypothesized that TLR4 activation
affects the healing of calvarial defects, and that different gene
expression patterns would be observed between wild-type (WT)
and Toll-like receptor 4 mutant (TLR42/2) mice during the
healing process. To test this hypothesis, we assessed bone healing
in small calvarial defects created in WT and TLR42/2 mice using
radiographic, histologic and gene expression analyses.
Materials and Methods
Animal care and experimental design
Wild-type C57BL-6J mice (Jackson, Bar Harbor, ME) and
TLR42/2 mice (from an ongoing breeding colony housed at the
University of Pittsburgh) between 10 and 12 weeks of age (20–
30 g) were used in this study. Mice were randomly chosen for
radiographic, histological, or RT-PCR analyses. All mice were
maintained in the Rangos Research Center Animal Facility,
Children’s Hospital of University of Pittsburgh with a 12:12 h
light-dark cycle and free access to standard laboratory food and
water. All procedures were carried out in accordance with the
regulations regarding the care and use of experimental animals
published by the National Institutes of Health and were approved
by the Institutional Animal Care and Use Committee of the
University of Pittsburgh.
Calvarial defects model
Mice were anesthetized by inhalation with isoflurane (4% for
induction, 2% for maintenance, Abbott Laboratories, Chicago).
The scalps were depilated and cleaned prior to surgery. Under
sterile conditions, the calvariae were exposed by midline scalp
incision and the periosteum covering the entire parietal bone was
stripped off. A circular parietal defect was made using a 1.8 mm
outer diameter trephine (Fine Science Tools, Foster City, CA).
The calvariae were irrigated with PBS during surgery. Following
creation of the defect, the scalp was reapproximated and closed
with 4-0 Vicryl resorbable sutures and 1 mg/kg ketoprofen (Fort
Dodge Animal Health, Fort Dodge, IA) was administered as an
analgesic immediately after surgery. All animals were euthanized
by CO2 overdose followed by cervical dislocation at designated
time points postoperatively.
Histologic analyses
Between three and five mice from each group were euthanized
on untreated day 0 and postoperative days 1, 4, 7, 14, 21 and 28.
Calvariae and surrounding soft tissues (e.g., skin, brain) were
harvested by cutting the skull bones anteriorly across the middle of
the frontal bones and posteriorly through middle of the
interparietal bone. The samples were fixed in 10% neutral
buffered formalin for 24–48 h and were decalcified overnight in
Cal-Ex decalcifer (Fisher Scientific, Hampton, N.H.) prior to being
dehydrated through a series of alcohols and embedded in paraffin.
Paraffin-embedded specimens were sectioned through the coronal
plane at a thickness of 5 mm. Three regions of each defect, 50 mm
apart, were cut and placed on slides (for a total of approximately
30 slides per animal). Slides were stained with Harris’ hematoxylin
& eosin (Surgipath Medical Industries, Richmond, IL) for
conventional, qualitative bright-field light microscopy.
Histomorphometric analysis was performed to quantify the two-
dimensional area of new bone formation. Healing data was
calculated based on three to five slides per animal. Microscopic
images of the histologic sections under 1006were analyzed using
Northern Eclipse software (Empix Imagine, Inc., Mississauga,
Ontario, Canada). New bone area was calculated as the sum of the
areas of each bone section, including within the defect and on both
sides of calvarial. Data were expressed as mean +/2 SEM.
Russell-Movat pentachrome staining (American MasterTech,
CA) was performed to further differentiate the following tissues
within the defect: hematoma/fibrin (intense red), elastic fibers
(black), cartilage (deep green), granulation/fibrous tissue (green or
light blue) formation and degradation, newly-formed woven bone
(yellow) and lamellar bone (red). All specimens were examined at
256, 506, 1006 and 2006magnifications.
Immunohistochemistry stain: Sections were deparaffinized with
xylenes and rehydrated through serial of EtOH dilutions to
distilled H2O. Following the manufacturer’s instructions, sections
were incubated in primary goat polyclonal anti-OPN (Santa Cruz
Biotechnology, Santa Cruz, CA) as a marker of osteogenic
differentiation suspended at a 1:250 dilution in 2% normal horse
serum (Vector Laboratories, Burlingame, CA) for 30 min at room
temperature, secondary antibody (biotinylated anti-goat, made in
horse, BA-9500, Vector Laboratories, Inc. CA, USA) diluted at
1:250 for 30 mins at room temperature, and with Streptavidin-
HRP (R&D systems, Gaithersburg, MD) at dilution 1:500 for
30 mins at room temperature. Color was developed by application
of DAB kit (Vector Laboratories, Burlingame, CA). Sections were
dehydrated and mounted prior to examination at 256, 506,
1006, and 2006magnifications.
Radiographic analysis
Ten animals from each group were euthanized 28 days after
surgery and calvariae were harvested and fixed in 10% neutral
buffered formalin for 24–48 hours. Radiographs were obtained
using a Faxitron MX-20 (Faxitron X-Ray, Lincolnshire, IL) with a
35 Kv exposure and a 45-second exposure time to analyze
calvarial healing. The films (Eastman Kodak, Rochester, NY) were
developed and scanned using a Microtek 9800 XL scanner
(Microtek Lab, Inc., Fontana, CA). The scanned images were
imported into Northern Eclipse software (Empix Imagine, Inc.,
Mississauga, Ontario, Canada). The remaining defect area was
measured, and subtracted from the geometric original defect area
(2.54 mm2) to generate the area of newly-formed bone.
mRNA extraction and expression analysis
Five to seven mice from each group per time point were killed at
day 0 before surgery and at 3 h, days 1, 2, 4, 7, 14, 21, 28
postoperatively. Samples surrounding the initial 1.8 mm defect
were collected using a 5.0 mm trephine (Fine Science Tools,
Foster City, CA), and included blood clots, hematoma, granula-
tion tissue, new bone and surrounding normal bone. Samples were
stored at 4uC in RNAlater solutions (Life Technologies, NY) until
ready for RNA isolation. The specimens were homogenized in
liquid nitrogen using a mortar and pestle, and RNA was extracted
from the sample using RNAqueous-Micro Kit (Life technologies,
NY) and the manufacturer’s protocol. Contaminating genomic
DNA was eliminated by treatment with DNAse I (Invitrogen, Life
Technologies). Primers used in the study recognize IL-1a, IL-1b,
IL-6, TNF-a, BMP-2, BMP-4, TGF-b1, TGF-b2, TGF-b3,
VEGF, PDGF, RANK, RANKL and OPG. The housekeeping
genes GAPDH and EEF2 were chosen as internal controls. RT-
PCR results were analyzed by standard curve analysis. Finally,
relative gene expression in WT and TLR42/2mice was compared
at designated time points.
Statistical analysis
Statistical analyses were performed using SPSS v.20.0 software
(SPSS, Inc, Chicago, IL). Mean areas of newly-formed bone
collected from histomophometric measurements were compared
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using a group by time point (264) two-way ANOVA followed by
group by time point (164) split plot one-way ANOVAs to compare
each group (either WT or TLR42/2) over time. Post-hoc LSD
tests for multiple comparisons were used to detemine significant
differences among groups and time points. Independent t-tests
were performed to compare histomorphometric and radiographic
measurements of newly-formed bone area in WT and TLR42/2
mice at each time point.
PCR data violated the assumption of homogeneity of variance,
so the data was transformed using a rank transformation. Data
were compared using two-way (time x group) ANOVA and are
compared according to ‘‘early’’(#4 days) and ‘‘late’’(.4 days) time
point groups. A p value less than or equal to 0.05 was considered
significant.
Results
Histologic analysis
Qualitative histologic analysis. Day 0: Similar histological
staining was shown in WT and TLR42/2 mice on day 0 using
H&E and Pentachrome stain (Figure 1A, B; Figure 2A, B).
Day 1-day 4: WT and TLR42/2 mice showed similar
histological staining patterns on day 1 and day 4 (Figure 1C, D;
Figure 2C, D). Hematoma was visible and infiltration by multiple
cell types was observed in H&E stained images. The bone defect
was filled with hematoma as early as day 1. No changes were
observed in the periosteal regions on day 1 (Figure 1C, D).
Evidence of hematoma degradation and a reduction in cellular
infiltrate was apparent by day 4. On the endocortical surface
(presumably derived from the dura mater), cells gathered along the
perimeter of the defect (Figure 1E, F). Dural cell layer was thicker
and OPN staining intensity were more pronounced in TLR42/2
mice than in WT mice (Figure 3A, B). No bone formation was
evident on day 4.
Day 7-day 14: Larger areas of newly-formed bone were seen in
TLR42/2 mice than in WT mice on day 7. Newly-formed
cellularized bone matrix, indicated by positive saffron yellow
staining (Figure 2E, F), was observed on the endocortical (dural)
side of the calvarial bone lateral to the defect perimeter in both
WT and TLR42/2 mice. The thickness of the dural cell layer was
diminished relative to day 4, and there was evidence of active bone
formation near the dural side of the calvaria. Disorganized loose
connective tissue completely filled the bone defect on day 7
(Figure 1G, H). OPN immunoreactivity was observed along the
ectocortical bone surface (periosteal side), along the endocortical
bone surface (dural side), within the intercortical region (bone
marrow or diploic space), and along the defect margins. OPN
immunostaining was more intense in TLR42/2 mice than WT
mice (Figure 3C, D). Typical large, rounded osteoblasts were
recognized on the surface of the newly-formed bone in WT and
TLR42/2 mice on day 14 (Figure 3E, F). Regenerated bone was
seen along the dural surface of the calvarial bone and along the
defect perimeter. Periosteal thickness remained unchanged
between days 7 and 14, while the loose connective tissue was
thinner and more organized (Figure 1I, J).
Day 21-day 28: Defects in WT and TLR42/2 mice were
histologically similar during this period. On day 21, active bone
formation was suggested by the presence of large regions of woven
bone matrix at the defect margin in WT and TLR42/2 mice
(Figure 1K, L). Mature OPN-positive osteoblasts were observed on
the surfaces of the woven bone. Dural cell layers returned to day1
thickness without OPN positive staining (Figure 3G, H). On day
28, less OPN positive staining and less bone formation was
detected in both WT and TLR42/2 mice (Figure 1M, N;
Figure 3I, J). Bone remodeling was evident with acid fuchsin red
positive staining (Figure 2G, H). Periosteum and soft connective
tissue became much thinner, more dense, and better organized
(Figure 1M, N).
Quantitative histologic analysis
No obvious bone formation was observed in either group before
day 7. Two-way ANOVA comparing mean newly-formed bone
areas showed a significant group by time point interaction
(F = 3.476; p,0.05) and significant group (F= 5.946; p,0.05)
and time point (F= 14.728; p,0.05) effects. One-way ANOVA
showed no significant differences in bone healing between days 21
and 28 in WT mice, or between days 14, 21, and 28 in TLR42/2
mice (p.0.05). Independent T-tests showed significant differences
in newly-formed bone areas between WT and TLR42/2 mice on
both days 7 and 14 (p,0.05, Figure 4). Larger newly-formed bone
areas were observed in TLR42/2 mice on days 7 and 14, although
comparable levels of bone healing were observed in both groups at
other time points (p.0.05; Figure 4).
Radiographic analysis
Mineralized tissue was observed on day 28 radiographs in WT
and TLR42/2 mice, although healing remained incomplete
during the 28 days of observation. Calculation of newly-formed
bone area as determined by radiography revealed healing
percentages of 33.14% and 26.83% (data not shown) in WT and
TLR42/2 mice, respectively. Independent T-test showed no
significant difference in bone healing area between WT (0.9378+/
20.1131 mm2; 33.14% healing) and TLR42/2 (0.6814+/
20.209 mm2; 26.83% healing) mice on day 28 (p.0.05, Figure 5).
Gene expression
Baseline expression of 14 genes (IL-1a, IL-1b, Il-6, TNF-a,
BMP2, BMP4, TGF-b1, TGF-b2, TGF-b3, VEGF, PDGF,
RANK, RANKL, and OPG) were measured by quantitative
RT-PCR using day 0 untreated samples. Expression of IL-1b and
VEGF was significantly different between the two groups.IL-1b
(24.52+/216.79 copy in WT; 5.30+/21.46 copy in TLR42/2)
and RANKL (6.90e-3+/24.10e-3 copy in WT;1.80e-3+/25.00e-
4 copy in TLR42/2) expression were higher in WT mice, and
VEGF (32.42+/215.90 copy in WT; 92.39+/21.64 copy in
TLR42/2) expression was higher in TLR42/2 mice on day 0
(Figure 6).
Changes in gene expression at designated time points were
determined by relative RT-PCR. The gene expression patterns for
IL-1a, IL-1b and TNF-a expression were similar in both groups.
Expression of these cytokines increased after surgery, remained
stable for a few days and then was upregulated on day 14 and day
21 postoperatively. Significantly higher expression of IL-1b was
detected by two-way ANOVA analysis at both early (F = 8.414,
p,0.05) and late (F= 26.17, p,0.001) time points in TLR42/2
than in WT mice. TNF-a expression was significantly higher at
early time points in TLR42/2 mice compared to WT mice
(F = 6.451, p,0.05) (Figure 7A, B, D). IL-6 exhibited a different
expression pattern in TLR42/2 mice, and showed significantly
higher fold change expression than in WT mice at early time
points postoperatively (F= 6.685, p,0.05) (Figure 7C).
BMP2 expression increased slightly after surgery in both groups,
peaking at day 14 (3.28+/21.02 fold in WT;1.59+/20.81 fold in
TLR42/2) and declining thereafter. No significant difference in
BMP2 expression was observed between the two groups
(Figure 8A). BMP4 expression was similar in both groups,
increasing slightly until day 21 (87.06+/272.08 fold in WT;
128.27+/280.39 fold in TLR42/2) and declining at day 28
Calvarial Healing in TLR4 Ko Mice
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Figure 1. Histophotomicrographs for H&E stained tissues at the defect margins at postoperative time points. WT and TLR42/2 mice
showed similar histological staining patterns on days 0, 1 and 4, while larger areas of newly-formed bone were seen in TLR42/2mice than in WT mice
on day 7. Newly-formed cellularized bone matrix was observed on the endocortical (dural) side of the calvarial bone lateral to the defect perimeter in
both groups since day 7. Active bone formation was suggested by the presence of large regions of woven bone matrix at the defect margin in both
groups on days 14 and 21. Defects in WT and TLR42/2mice were histologically similar since day 21. (scale bar: 100 mm; bolded arrows: defect margin;
Calvarial Healing in TLR4 Ko Mice
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(18.24+/213.53 fold in WT; 2.56+/21.77 fold in TLR42/2). No
significant difference in BMP4 expression was observed between
the two groups (Figure 8B).
Significant differences of TGF-b1 were observed in TLR42/2
mice compared to WT mice at early time points (F = 22.636,
p,0.001) (Figure 8C). No significant differences were detected in
the expression of TGF-b2 between groups (Figure 8D). A similar
pattern in TGF-b3 expression was observed in both groups.
Expression remained stable between 3 h and day 7, and achieved
a peak in expression at day 14 (12.69+/23.55 fold in WT;
26.42+/210.58 fold in TLR42/2). While the pattern of TGF-b3
expression was similar between the two groups, significantlly
higher expression of TGF-b3 was observed in TLR42/2 mice
than in WT mice (F = 15.283, p,0.001)(Figure 8E). The fold
change expression patterns of VEGF and PDGF in WT and
TLR42/2 mice were similar. Expression of VEGF in WT and
TLR42/2 remained relatively constant until it was upregulated at
day 14 (7.90+/25.25 fold in WT;1.17+/20.02 fold in TLR42/2),
endo: endocortical surface of calvarial bone; ecto: ectocortical surface of calvarial bone; H: hematoma; IC: infiltrating cells; LB: lamellar bone; WB:
woven bone; NFB: newly-formed bone; DC: dural cells).
doi:10.1371/journal.pone.0046945.g001
Figure 2. Histophotomicrographs of slides stained with OPN antibodies using immunohistochemistry. OPN staining intensity were
more pronounced in TLR4-/- mice than in WT mice on postoperative days 4 and 7. Typical large, rounded osteoblasts were recognized on the surface
of the newly-formed bone in both groups on day 14. On day 28, less OPN positive staining was detected in both WT and TLR42/2 mice. (scale bar:
100 mm; bolded black arrows: defect margin; LB: lamellar bone; WB: woven bone; OPN(+): OPN positive stains; OB: osteoblasts).
doi:10.1371/journal.pone.0046945.g002
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and began to decrease thereafter. Significantly lower expression of
VEGF was detected in TLR42/2 mice than in WT mice
(F = 31.258, p,0.001). PDGF expression was stable in both WT
and TLR42/2 mice at all time points. Significantly higher
expression of PDGF was observed in TLR42/2 mice compared to
WT mice at early time points (F = 4.157, p,0.05) (Figure 8F, G).
High expression level of RANK was detected on day 14 in WT
mice (16.50+/215.94 fold), while expression level in TLR42/2
Figure 3. Histophotomicrographs of pentachrome stained tissues in WT and TLR42/2mice. Similar stains were observed between WT and
TLR42/2 mice on day 0 and day 1. An increased amount of newly-formed bone was observed in TLR42/2 mice at day 7, suggesting accelerated
healing compared to WT. Lamellar bone (*), which stains positive for acid fuchsin (red) was observed in both groups on day 28, suggesting
maturation and remodeling of the newly formed bone matrix. (scale bar: 100 mm; bolded black arrows: defect margin; LB: lamellar bone; NFB: newly-
formed bone).
doi:10.1371/journal.pone.0046945.g003
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was similar at all time points. Fold change expression of RANK in
TLR42/2 was significantly lower than in WT mice at both early
(F = 4.453, p,0.05) and late time points (F = 6.522, p,0.05)
(Figure 9A). Expression patterns of RANKL and OPG were
relatively stable in WT mice. In TLR42/2 mice, both RANKL
and OPG were slightly increased at early time points (#4 days)
and decreased at day 7. Expression level of RANKL was
significantly higher in TLR42/2 mice at early time points
(F = 4.199, p,0.05) and significantly lower at late time points
compared to WT mice (F = 56.217, p,0.001). Fold change
expression of OPG in TLR42/2 was significantly lower than in
WT mice at late time points (F = 83.961, p,0.001). (Figure 9B,
9C).
Discussion
Inflammation has a complex role in fracture repair, although
the underlying mechanisms remain unclear [15–17]. TLR4 is a
member of a highly conserved receptor family and is a critical
activator of the innate immune response after tissue injury. TLR4
signaling has been shown to regulate both the immune response
and bone metabolism during long-bone fracture healing. Here, we
tested the hypothesis that TLR4 activation limits the healing of
calvarial defects.
In this study, a smaller than ‘‘critical-size’’ calvarial defect
model was used, which by definition, would be expected to heal
spontaneously over the duration of the observation. However,
none of our 1.8 mm diameter defects healed complete during 28
days of observation. The maximum healing was approximately
30% of the original defect area, which is consistent with previous
observations by Gosain et al., who observed 27–35% healing of
critical-size defects at 4 weeks [18]. Importantly, we found that no
significant healing occurred after 21 days in this model.
Pentachrome staining of day 28 defects supports this observation.
The newly-formed woven bone adjacent to the defect perimeter
stained with acid fuchsin red, suggesting that bone remodeling had
already taken place by day 28. OPN reactivity suggests that bone
formation, which was highly active around day 21 in WT mice
and day 14 in TLR42/2 mice, became less active and less OPN-
positive staining was observed. Thus, there may exist a temporal
window for mature calvarial healing even in defects smaller than
‘‘critical-size’’. The molecular signaling involved in the cessation of
bone formation within such bone defects need to be further
characterized.
Although no significant difference in total calvarial healing was
observed between groups radiographically or histologically on
post-operative day 28, accelerated healing was observed in
TLR42/2 mice. By day 4, a thicker dural cell layer and more
dense OPN positive stains were evident in TLR42/2 mice. By day
7, a quantity of newly-formed woven bone was seen on the
endocortical calvarial surface in TLR42/2 mice. Quantitative
histomorphometry data was consistent with the histological
findings mentioned above. Two-way ANOVA comparing mean
newly-formed bone areas showed a significant group by time point
interaction, suggesting that the WT and TLR42/2 mice healed
Figure 4. Graph showing newly-formed bone areas measured
from H&E stained histology slides. No obvious bone healing was
seen before day 7. Significant differences in bone healing areas were
observed between WT and TLR42/2 mice on days 7 and 14
postoperatively. Newly-formed bone areas were not significantly
different after day 21 in WT mice or after day 14 in TLR42/2 mice
(mean +/2 SEM ; *p,0.05).
doi:10.1371/journal.pone.0046945.g004
Figure 5. Graph showing similar amounts of radiographically
opaque tissue observed on day 28 in both groups. Independent
t-test showed no significant differences between the calvarial healing of
WT and TLR42/2 mice at this time point. Out of 20 mice tested, none
showed complete healing during the 28 days of observation. (mean +/
2SEM; n= 10 each).
doi:10.1371/journal.pone.0046945.g005
Figure 6. Graph showing quantitative gene expression on day
0 (untreated control) bone tissue. Siginificant differences were
identified in the expression of IL-1b,VEGF and RANKL between the two
groups. IL-1b and RANKL expression were higher in WT mice and VEGF
expression was higher in TLR42/2 mice on day 0 (mean +/2SEM; n = 5
to 7; *p,0.05).
doi:10.1371/journal.pone.0046945.g006
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differently over time. It showed significantly larger area of new
bone in TLR42/2 mice on day 7 and day 14. Similarly, improved
bone healing has been reported for long bone fracture healing in
mice lacking an adaptive immune system. Specifically, in RAG12/
2 mice (recombination activating gene 1 knockout), increased
bone formation and biomechanical strength at early time points
was associated with reduced pro-inflammatory cytokine expression
and increased expression of the anti-inflammatory cytokine, IL-10
[7]. Those observations suggest that the suppression of the
adaptive immune system might maximize the regenerative and
minimize the destructive effects of inflammation which may
promote fracture repair [7]. In our model, bone healing was
obviously accelerated in TLR42/2 mice, although the total bone
healing achieved was comparable between two groups. Whether
accelerated calvarial healing effect is due to the suppression of
TLR4-mediated inflammatory response requires further explora-
tion.
Gene expression analysis showed that expression of inflamma-
tory cytokines, generally, was elevated 3 hour post-operatively,
and a second spike in inflammatory gene expression was detected
around day 14 in both groups. Greater variation was detected in
the expression of growth factors after surgery. These findings are
consistent with the gene expression patterns described in long bone
fracture models [19–20]. Of greater interest, we found that IL-1b,
IL6 and TNF-a,TGF-b1, TGF-b3 and PDGF were more highly
expressed at earlier time points in TLR42/2 mice. We speculated
that accelerated bone healing observed in TLR42/2 mice might,
at least in part, be due to earlier and higher expression of these
genes [21–23].
The inflammatory cytokines IL-1b, IL-6 and TNF-a have
complex effects on bone regeneration. IL-1b can stimulate
osteoblasts and bone matrix formation, but also suppress the
differentiation of mMSCs [24]. In vivo studies in IL1a, IL1b, and
IL1a/b mutant mice have shown impaired osteoclast development
to result in increased bone density and femoral bone mass within
these animal models [25]. IL-6 has been shown to both promote
and inhibit osteoclastogenesis [26–27]. An in vivo study deter-
mined that the absense of IL-6 promoted inflammatory calvarial
bone loss in a mouse model [28]. Although IL-62/2 mice showed
reduced osteoclastogenesis and impaired callus strength at the
early time points after surgery, similar long bone healing outcomes
were observed in comparison with WT mice after 3 weeks [29].
Therefore, the role of IL-6 in osteoclastogenesis has been more
elucidated [28–29]. Further studies are needed to understand the
impact of TLR4-mediated inflammatory and related inflammato-
ry cytokines expression on calvarial bone repair.
RANK, OPG and RANKL are important mediators of
remodeling during bone formation and bone regeneration. TLR
signaling inhibits RANKL-mediated osteoclastogenesis, although
TLR activation can also promote osteoclastogenesis by inducing
Figure 7. Graph showing relative fold change expression of inflammatory cytokines for WT and TLR42/2 mice (mean fold change
over day 0; ND, not detectable). The fold change patterns in IL-1a, IL-1b, and TNF-a expression were similar in both groups. IL-6 had a different
expression pattern in TLR42/2 mice compared to WT mice at early time points (mean +/2SEM; n= 5 to 7).
doi:10.1371/journal.pone.0046945.g007
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Figure 8. Graph showing relative fold change expression of growth factors for WT and TLR42/2mice (mean fold change over day 0;
ND, not detectable). Similar expression patterns of BMP2, BMP4, TGF-b2, VEGF, and PDGF were observed between the two groups. Higher
expression levels of TGF-b1 and TGF-b3 were detected in TLR42/2 mice than in WT mice at early time points (mean +/2SEM; n= 5 to 7).
doi:10.1371/journal.pone.0046945.g008
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RANK and TNF-a expression in osteoblasts [9]. In the present
study, significant differences were apparent in the expression of
RANK, OPG and RANKL between TLR42/2 and WT mice.
Expression of RANKL was significantly higher in TLR42/2 mice
compared to WT mice at early time points. RANK, RANKL and
OPG all showed significantly lower expression in TLR42/2 mice
than in WT mice at late time points. During long bone
regeneration, upregulated RANKL at primary long bone forma-
tion stage is associated with mineralized cartilage resorption and
bone formation, and downregulated expression indicated bone
remodeling. Early high expression levels in TLR4-/- mice suggest
early and high resorption activity of osteoclasts. The differential
expression of these three genes might explain the observed
accelerated bone formation and early bone remodeling in
TLR42/2 mice. It remains unclear whether differenes in RANK,
RANKL and OPG expression are directly linked to the absence of
TLR4 signaling.
Conclusion: The present study revealed accelerated bone
formation and bone remodeling in absence of TLR4 signaling
pathway. This phenotype is also associated with changes of local
inflammatory cytokines and osteoclastogenic factors expression.
Further work is required to determine whether regenerative effects
of inflammation mediated by absence of TLR4 may lead to
accelerated skull bone repair.
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